CN111825726A - Benzimidazole catalyst and preparation method thereof - Google Patents

Benzimidazole catalyst and preparation method thereof Download PDF

Info

Publication number
CN111825726A
CN111825726A CN202010766030.9A CN202010766030A CN111825726A CN 111825726 A CN111825726 A CN 111825726A CN 202010766030 A CN202010766030 A CN 202010766030A CN 111825726 A CN111825726 A CN 111825726A
Authority
CN
China
Prior art keywords
compound
benzimidazole
catalyst
pph
reacting
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202010766030.9A
Other languages
Chinese (zh)
Inventor
柴肖芳
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN202010766030.9A priority Critical patent/CN111825726A/en
Publication of CN111825726A publication Critical patent/CN111825726A/en
Pending legal-status Critical Current

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • C07F15/04Nickel compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D235/14Radicals substituted by nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • C07F15/0006Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table compounds of the platinum group
    • C07F15/006Palladium compounds
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08FMACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F232/00Copolymers of cyclic compounds containing no unsaturated aliphatic radicals in a side chain, and having one or more carbon-to-carbon double bonds in a carbocyclic ring system
    • C08F232/08Copolymers of cyclic compounds containing no unsaturated aliphatic radicals in a side chain, and having one or more carbon-to-carbon double bonds in a carbocyclic ring system having condensed rings
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08FMACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F4/00Polymerisation catalysts
    • C08F4/42Metals; Metal hydrides; Metallo-organic compounds; Use thereof as catalyst precursors
    • C08F4/44Metals; Metal hydrides; Metallo-organic compounds; Use thereof as catalyst precursors selected from light metals, zinc, cadmium, mercury, copper, silver, gold, boron, gallium, indium, thallium, rare earths or actinides
    • C08F4/60Metals; Metal hydrides; Metallo-organic compounds; Use thereof as catalyst precursors selected from light metals, zinc, cadmium, mercury, copper, silver, gold, boron, gallium, indium, thallium, rare earths or actinides together with refractory metals, iron group metals, platinum group metals, manganese, rhenium technetium or compounds thereof
    • C08F4/70Iron group metals, platinum group metals or compounds thereof
    • C08F4/7001Iron group metals, platinum group metals or compounds thereof the metallic compound containing a multidentate ligand, i.e. a ligand capable of donating two or more pairs of electrons to form a coordinate or ionic bond
    • C08F4/7003Bidentate ligand
    • C08F4/7004Neutral ligand
    • C08F4/7006NN

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

The structural formula of the benzimidazole catalyst is shown as the formula I:
Figure DDA0002614662130000011
reacting compound D with [ R ]4NiCl(PPh3)2]Or is [ R4PdCl(PPh3)2]Dissolving in anhydrous tetrahydrofuran, reacting at 30-50 deg.C for 5-10h, and post-treating to obtain benzimidazole catalyst (formula I). The catalyst of the invention isCan still catalyze olefin polymerization at high temperature (120 ℃) and has good activity.

Description

Benzimidazole catalyst and preparation method thereof
Technical Field
The invention belongs to the field of polymerization of cycloolefins, and particularly relates to a benzimidazole catalyst and a preparation method thereof.
Background
Cycloolefin copolymers (cyclic-olefin copolymers) are high value-added thermoplastic engineering plastics prepared by copolymerizing a cycloolefin monomer and alpha-olefin [ ethylene, E, propylene, P ], and the like. The cycloolefin copolymer is usually prepared by addition polymerization and copolymerization of cycloolefin and alpha-olefin. Compared with the traditional polyolefin, the main chain is introduced with a ring structure, so that the transparency, heat resistance, chemical stability, dielectric property, melt fluidity, thermal insulation and the like of the polyolefin can be effectively improved, and the polyolefin has potential application prospects in the fields of optical devices, automobiles, packaging, electronic appliances and the like.
The most common cyclic olefin coThe copolymer is an ethylene/norbornene copolymer, and the cycloolefin material has many excellent properties but has some defects. For cyclic olefin copolymers, the glass transition temperature (T) of the polymer material increases with the insertion rate of the cyclic olefin monomerg) Exhibit an increasing tendency, and a high comonomer insertion rate often leads to a decrease in the toughness of the material, which has limited the use of ethylene/norbornene copolymers. It was found that when the insertion rate of norbornene is higher than 54 mol%, the glass transition temperature of the ethylene/norbornene copolymer can reach 150 ℃ which is comparable to the T of PCgThe values are similar, however, the norbornene content in the polymer is too high, the brittleness of the polymer material is large, and the toughness is obviously reduced. Therefore, efforts are being made to synthesize novel cycloolefin copolymers, and it is desired that toughness and glass transition temperature of the material can be improved at the same time. The glass transition temperature is an important indicator of the heat resistance of a material and is an important parameter for whether a polymeric material can maintain dimensional stability at high temperatures. The introduction of the bulky steric monomers into the cycloolefin polymer is an important method for improving the glass transition temperature of the cycloolefin polymer, and the introduction of the bulky steric monomers enables the polymer material to have higher glass transition temperature under relatively lower insertion rate of the cycloolefin monomers, and at the moment, the polymer chain also has more ethylene chain segments, the molecular chain is more flexible, the chain entanglement density is larger, so the toughness of the material is also improved. The molecular chain of the vinyl addition polymer taking the norbornene and the derivative thereof as raw materials does not contain C ═ C double bonds, so that the chemical property is more stable, and the application property is better. At present, in the binary and ternary polymerization research of norbornene and alpha-olefin, by introducing monomers with different performances, the method not only effectively improves the high brittleness and the glass transition temperature (T) of polynorborneneg) High solubility and the like, and can synthesize functional COCs with excellent physical and mechanical properties according to the types of comonomers and different structures of polymers. With the demand of people on the application of cycloolefin materials, novel catalysts for catalyzing and synthesizing functional cycloolefin materials are continuously developed, and are well used for catalyzing the copolymerization of norbornene, ethylene and propylene, but in the preparation of norbornene/high-grade norborneneThe alpha-olefin copolymer aspect is still relatively limited. Compared with the former transition metal catalyst, the latter transition metal catalyst has become a research hotspot in the field of olefin polymerization catalysts due to the advantages of simple synthesis, good stability, weak oxophilicity, strong tolerance to heteroatoms and the like, and the nickel catalyst is cheaper and easily available than the palladium catalyst, has good industrial application prospect and has unique performance in the aspect of catalytically synthesizing cycloolefin copolymers. However, since the nickel complex is easy to deactivate or even inactivate at high temperature (above 60 ℃) in the process of catalyzing olefin polymerization, and the high temperature resistance is generally poor, the ligand steric hindrance and the electronic effect need to be further designed to synthesize the nickel catalyst with high catalytic activity and good thermal stability, and effectively catalyze the copolymerization of norbornene and high-grade alpha-olefin.
Disclosure of Invention
In view of the above technical problems, the present invention aims to provide a benzimidazole catalyst with a completely new structure. In order to achieve the purpose, the invention adopts the following technical scheme, wherein the benzimidazole catalyst has the following structural formula:
Figure BDA0002614662110000021
wherein formula R1,R4Is C1-C6Alkyl, phenyl or substituted phenyl, wherein the substituents on the phenyl ring are C1-C6Alkyl, halo C1-C6Alkyl, CN, NO2、COOH,R2,R3Is selected from H, C1-C6Alkyl, halo C1-C6Alkyl, OH, CN, NO2COOH, M is a nickel atom or a palladium atom.
The invention also provides an intermediate for preparing the compound of the formula I, which has the structure
Figure BDA0002614662110000022
Wherein R is1-R3Is as defined in claim 1.
The invention also provides a preparation method of the compound shown in the formula I, which comprises the following steps:
step 1, sequentially adding a compound A, a compound, potassium peroxymonosulfonate and a solvent into a reactor, wherein the molar ratio of the compound A to the compound B to the potassium peroxymonosulfonate is 1 (1-3) to (1-3), and further preferably 1 (1-1.5) to (1-2), the solvent is selected from acetonitrile, DMF, DMSO and toluene, further preferably toluene and DMF, the mass-to-volume ratio of the compound A to the solvent is 40mL/g-80mL/g, further preferably 40mL/g-50mL/g, the reaction temperature is 120-150 ℃, the reaction time is 3-5 hours, and the compound C can be obtained by adopting the conventional aftertreatment in the field;
step 2-in the reactor, adding anhydrous tetrahydrofuran, and reacting the compound C with the compound R1NH2Adding anhydrous magnesium sulfate in titanium tetrachloride as catalyst, reacting at 40-70 deg.C for 2-3 hr, and performing conventional post-treatment in the field to obtain compound D, wherein compound C and R1NH2The molar ratio of the raw materials is 1: (1-5), and more preferably 1: (1-2), wherein titanium tetrachloride accounts for 1-5% of the weight ratio of the compound C, anhydrous magnesium sulfate accounts for 50-80% of the weight ratio of the compound C, and the mass-volume ratio of the compound C to anhydrous tetrahydrofuran is 20-25 mL/g;
step 3-reaction of Compound D with [ R ]4NiCl(PPh3)2]Or is [ R4PdCl(PPh3)2]Dissolving in solvent, reacting at 30-50 deg.C for 5-10h, and performing conventional post-treatment in the art to obtain compound of formula I, wherein the solvent is selected from acetonitrile, anhydrous tetrahydrofuran, dichloromethane, dichloroethane, and further selected from acetonitrile, anhydrous tetrahydrofuran, dichloromethane, compound D and [ R ]4NiCl(PPh3)2]Or is [ R4PdCl(PPh3)2]In a molar ratio of 1: (1-5), and more preferably 1: (1-2), wherein the mass-volume ratio of the compound D to the solvent is 15mL/g-40mL/g, more preferably 15mL/g-20mL/g, and the benzimidazole catalyst (formula I) is obtained by post-treatment, and the structural formula of the compound A-the compound D is shown in the specification, wherein R is1-R4As defined in claim 1:
Figure BDA0002614662110000031
the invention also relates toProvides an application of norbornene and terminal linear olefin copolymerization, which comprises the following steps: under the protection of inert gas, toluene solution is added in turn, and cocatalyst ethyl aluminum dichloride (EtAlCl) is added in turn at 80-120 DEG C2) The toluene solution and the norbornene/1-hexene mixed solution with different proportions are quickly added into the toluene solution containing the benzimidazole catalyst (the compound shown in the formula I) by an injector under the stirring speed of 300r/min for reaction for 1-3h, the reaction is stopped by acidified ethanol solution (the volume ratio of ethanol to hydrochloric acid is 90:10), the mixture is fully stirred and filtered, and the mixture is washed by ethanol for 3 times and then is dried in a vacuum oven to constant weight.
Wherein the norbornene/1-hexene mixed solution with different proportions is prepared from norbornene and 1-hexene according to the mass ratio of 1 (0.2-0.6), the molar ratio of the benzimidazole catalyst to the norbornene is (0.3% -0.7%): 1, and the cocatalyst EtAlCl is2The mass ratio of the benzimidazole catalyst to the benzimidazole catalyst is (5-15): 1.
the invention has the following beneficial effects:
1. the benzimidazole catalyst (compound shown in the formula I) of the invention obviously improves the stability of the nickel complex by introducing imidazole groups and imine groups.
2. The benzimidazole catalyst has larger steric hindrance effect, can effectively promote the copolymerization of norbornene and 1-hexene, and realizes the toughness increase of the cycloolefin copolymer without changing the glass transition temperature (T) of the cycloolefin copolymergValue).
Drawings
Fig. 1 is a schematic diagram of the crystal structure of example 1.
Detailed Description
The present invention is further described with reference to the following specific examples, but the scope of the present invention is not limited to the following examples. The method is a conventional method unless otherwise specified. The starting materials are commercially available from the open literature unless otherwise specified.
EXAMPLE 1 preparation of Compounds of formula I
Figure BDA0002614662110000041
Step 1-o-phenylenediamine (0.216g, 2mmol), 1-oxo-3, 4-dihydro-2H-naphthalene-2-carbaldehyde (0.383g, 2.2mmol) and potassium peroxymonosulfonate (2.459g,4mmol) are added into a reactor, 9mL DMF is added to be stirred and dissolved, the reaction is carried out for 5 hours at 120 ℃, 0.01mol/L sodium sulfite solution is added to quench the oxidant after the reaction is finished, the oxidant is diluted by 50mL water and extracted by dichloromethane, and then the compound C with the yield of 85 percent is obtained by column chromatography, and the structure of the compound C is confirmed by nuclear magnetism.1H NMR(400MHz,CDCl3)7.63–7.54(m,3H),7.34(s,1H),7.25(d,J=9.1Hz,2H),7.21–7.16(m,2H),6.95(s,1H),4.18(s,1H),2.94(d,J=1.6Hz,2H),2.54(s,1H),2.39(s,1H).13CNMR(100MHz,CDCl3)200.9,150.3,141.6,137.9,135.7,134.6,129.0,127.3,122.8,122.4,118.3,114.8,45.7,28.1,22.9.
Step 2-0.446 g of Compound C and 0.158g of aniline were added to a reactor, and 0.01g of titanium tetrachloride, 0.246g of anhydrous magnesium sulfate and 9mL of anhydrous tetrahydrofuran were added, reacted at 40 ℃ for 3 hours, spin-dried, and subjected to column chromatography to give 0.544g of intermediate Compound D, which was 95% in yield and was confirmed to be Compound D by nuclear magnetism.1H NMR(400MHz,CDCl3)7.68–7.52(m,2H),7.28(m,8H),7.17(s,1H),7.06(d,J=17.0Hz,2H),4.47(s,1H),2.95(d,J=1.6Hz,2H),2.63(s,1H),2.30(s,1H).13C NMR(100MHz,CDCl3)166.7,150.1,149.9,138.0,138.0,137.9,132.4,131.6,129.1,129.1,129.0,128.1,128.1,125.6,122.8,122.4,121.8,121.8,118.3,114.8,42.3,28.1,25.2;[M+H]:338.4261.
Step 3-0.544 g of Compound D with 0.211g CH3NiCl(PPh3)2Dissolving in 8.5mL of anhydrous tetrahydrofuran, reacting for 5h at 50 ℃, cooling and crystallizing to obtain 0.435g of benzimidazole catalyst, and determining the structure by XPRD single crystal diffraction.
The use of the compound of formula I as shown in example 1 for the copolymerization of norbornene with terminal linear olefins comprises the following steps:
0.435g of the compound of the formula I shown in example 1 is introduced into a round-bottomed flask and dissolved in 3mL of toluene until use, under an inert gas blanketAdding 50mL of toluene solution, and sequentially adding 1mol/L of cocatalyst EtAlCl at 120 DEG C26.8mL of a toluene solution and 21.4g of a mixed solution of norbornene and 1-hexene in a mass ratio of 1:0.2 were quickly added by syringe to the toluene solution containing the benzimidazole catalyst while stirring at a rate of 300 r/min. After reacting for a period of time, dropwise adding an acidified ethanol solution (ethanol/hydrochloric acid volume ratio is 90:10) to terminate the reaction, fully stirring, filtering, washing with ethanol for 3 times, and drying in a vacuum oven to constant weight.
EXAMPLE 2 preparation of Compound of formula 2
Figure BDA0002614662110000051
Step 1-3, 4-diaminotoluene (0.244g,2mmol), 1-oxo-3, 4-dihydro-2H-naphthalene-2-carbaldehyde (0.418g, 2.4mmol) and potassium peroxymonosulfonate (2.459g,4mmol) were added to a reactor, 11mL of dmf was added and stirred to dissolve, reaction was carried out at 150 ℃ for 3 hours, 0.01mol/L of sodium sulfite solution was added to quench the oxidant after the reaction was completed, and after dilution with 50mL of water, extraction was carried out with dichloromethane, and then column chromatography was carried out to obtain 0.492g of compound C, the yield was 89%, and the structure of compound C was confirmed by nuclear magnetism.1HNMR(400MHz,CDCl3)7.64-7.47(m,3H),7.34(s,1H),7.22-7.14(m,2H),7.11(s,1H),6.92(s,1H),4.18(s,1H),2.94(d,J=1.6Hz,2H),2.54(s,1H),2.44-2.31(m,4H).13CNMR(100MHz,CDCl3)200.9,150.3,141.6,137.1,135.8,135.7,134.6,132.7,129.0,129.0,127.3,123.7,117.5,113.8,45.7,28.1,22.9,21.2.
Step 2-0.492 g of Compound C and 0.191g of p-toluidine were charged into a reactor, and 0.01g of titanium tetrachloride, 0.257g of anhydrous magnesium sulfate and 12mL of anhydrous tetrahydrofuran were added, reacted at 40 ℃ for 2 hours, spin-dried, and subjected to column chromatography to obtain 0.625g of intermediate Compound D, which was 96% in yield and was confirmed to be Compound D by nuclear magnetism.1HNMR(400MHz,CDCl3)7.59(d,J=9.0Hz,2H),7.31(d,J=0.9Hz,2H),7.26-7.17(m,3H),7.16-7.10(m,3H),7.02(s,1H),6.94(s,1H),4.52(s,1H),3.00(d,J=1.6Hz,2H),2.61(s,2H),2.46-2.38(m,3H),2.37-2.27(m,3H).13C NMR(100MHz,CDCl3)166.7,150.1,149.5,138.0,137.1,135.8,134.8,132.7,132.4,131.6,130.2,130.2,129.0,128.1,128.1,123.9,123.9,123.7,117.5,113.8,42.3,28.1,25.2,21.2,21.1.
Step 3-0.625 g of Compound D with 0.194g CH3NiCl(PPh3)2Dissolving in 12mL of anhydrous tetrahydrofuran, reacting at 30 ℃ for 10h, cooling and crystallizing to obtain 0.482g of benzimidazole catalyst.
EXAMPLE 3 preparation of the Compound of formula 3
Figure BDA0002614662110000061
Step 1-3, 4-diaminotoluene (0.244g,2mmol), 1-oxo-3, 4-dihydro-2H-naphthalene-2-carbaldehyde (0.453g,2.6mmol), potassium peroxymonosulfonate (2.459g,4mmol) were added to a reactor, 10mL of dmf was added and stirred to dissolve, reaction was carried out at 130 ℃ for 4 hours, 0.01mol/L of sodium sulfite solution was added to quench the oxidizing agent after the reaction was completed, and after dilution with 50mL of water, extraction was carried out with dichloromethane, after which column chromatography was carried out to obtain 0.492g of compound C, yield was 89%, the structure of compound C was confirmed by nuclear magnetism, 1H NMR (400MHz, CDCl3)7.64-7.47(m,3H),7.34(s,1H),7.22-7.14(m,2H),7.11(s,1H),6.92(s,1H),4.18(s,1H),2.94(d, J ═ 1.6Hz,2H) 2.54(s,1H),2.44-2.31(m,4H).13C NMR (100MHz, CDCl3)200.9,150.3,141.6,137.1,135.8,135.7,134.6,132.7,129.0,129.0,127.3,123.7,117.5,113.8,45.7,28.1,22.9,21.2.
Step 2-0.492 g of Compound C and 0.287g of p-trifluoromethylaniline were charged into a reactor, and 0.01g of titanium tetrachloride, 0.257g of anhydrous magnesium sulfate and 25mL of anhydrous tetrahydrofuran were added, reacted at 40 ℃ for 2 hours, dried by spinning, and subjected to column chromatography to obtain 0.694g of intermediate Compound D, which was 93% in yield and confirmed to be Compound D by nuclear magnetism. 1H NMR (400MHz, CDCl3)7.57-7.50(m,5H),7.37-7.26(m,3H),7.19(s,1H),7.11(d, J ═ 1.7Hz,2H),7.05(s,1H),4.38(s,1H),2.98(d, J ═ 1.6Hz,2H),2.71(s,1H),2.40(s,3H),2.32(s,1H).13C NMR (100MHz, CDCl3)166.7,155.4,150.1,138.0,137.1,135.8,132.7,132.4,131.6,129.0,128.1,128.1,127.3,126.9,126.9,124.5,123.7,122.4,117.5,113.8,42.3,28.1,25.2,21.2.
Step 3-converting 0.694g intoCompound D with 0.155g CH3NiCl(PPh3)2Dissolving in 9mL of anhydrous tetrahydrofuran, reacting at 50 ℃ for 8h, and cooling and crystallizing to obtain 0.461g of benzimidazole catalyst.
EXAMPLE 4 preparation of the Compound of formula 4
Figure BDA0002614662110000071
Step 1-o-phenylenediamine (0.216g, 2mmol), 1-oxo-3, 4-dihydro-2H-naphthalene-2-carbaldehyde (0.383g, 2.2mmol) and potassium peroxymonosulfonate (2.459g,4mmol) are added into a reactor, 9mL DMF is added to be stirred and dissolved, the reaction is carried out for 5 hours at 120 ℃, 0.01mol/L sodium sulfite solution is added to quench the oxidant after the reaction is finished, the oxidant is diluted by 50mL water and extracted by dichloromethane, and then the compound C with the yield of 85 percent is obtained by column chromatography, and the structure of the compound C is confirmed by nuclear magnetism.1H NMR(400MHz,CDCl3)7.63–7.54(m,3H),7.34(s,1H),7.25(d,J=9.1Hz,2H),7.21–7.16(m,2H),6.95(s,1H),4.18(s,1H),2.94(d,J=1.6Hz,2H),2.54(s,1H),2.39(s,1H).13CNMR(100MHz,CDCl3)200.9,150.3,141.6,137.9,135.7,134.6,129.0,127.3,122.8,122.4,118.3,114.8,45.7,28.1,22.9.
Step 2-adding 0.446g of Compound C and 0.158g of aniline to a reactor, and adding 0.01g of titanium tetrachloride, 0.246g of anhydrous magnesium sulfate and 9mL of anhydrous tetrahydrofuran, reacting at 40 ℃ for 3 hours, spin-drying the solvent, and then performing column chromatography to obtain 0.544g of intermediate Compound D, the yield of which is 95%, which was confirmed to be Compound D by nuclear magnetism.1H NMR(400MHz,CDCl3)7.68–7.52(m,2H),7.28(m,8H),7.17(s,1H),7.06(d,J=17.0Hz,2H),4.47(s,1H),2.95(d,J=1.6Hz,2H),2.63(s,1H),2.30(s,1H).13C NMR(100MHz,CDCl3)166.7,150.1,149.9,138.0,138.0,137.9,132.4,131.6,129.1,129.1,129.0,128.1,128.1,125.6,122.8,122.4,121.8,121.8,118.3,114.8,42.3,28.1,25.2。
Step 3-0.544 g of Compound D is reacted with 0.211gCH3PdCl(PPh3)2Dissolving in 8.5mL of anhydrous tetrahydrofuran, reacting at 50 deg.C for 5h, cooling, crystallizing0.398g of benzimidazole catalyst was obtained.

Claims (7)

1. A benzimidazole catalyst is characterized in that the structural formula of the catalyst is shown as a formula I:
Figure FDA0002614662100000011
wherein R is1,R4Is C1-C6Alkyl, phenyl or substituted phenyl, wherein the substituents on the phenyl ring are C1-C6Alkyl, halo C1-C6Alkyl, CN, NO2,COOH,R2,R3Is selected from H, C1-C6Alkyl, halo C1-C6Alkyl, OH, CN, NO2COOH, M is a nickel atom or a palladium atom.
2. A benzimidazole compound has the structure
Figure FDA0002614662100000012
Wherein R is1-R3Is as defined in claim 1.
3. The process for preparing a benzimidazole catalyst according to claim 1,
step 1, adding a compound A, a compound B and potassium peroxymonosulfonate into a reactor, reacting for 3-5 hours at the temperature of 120-150 ℃ by taking DMF as a solvent, and carrying out post-treatment to obtain a compound C;
step 2-in the reactor, adding anhydrous tetrahydrofuran, and reacting the compound C with the compound R1NH2Adding anhydrous magnesium sulfate in the presence of titanium tetrachloride as a catalyst, reacting at 40-70 ℃ for 2-3 hours, and carrying out post-treatment to obtain a compound D;
step 3-reaction of Compound D with [ R ]4NiCl(PPh3)2]Or is [ R4PdCl(PPh3)2]Dissolving in anhydrous tetrahydrofuran, reacting at 30-50 deg.C for 5-10 hr, and filteringAfter post-treatment, the benzimidazole catalyst (formula I) is obtained
Figure FDA0002614662100000013
Wherein R is1-R4Is as defined in claim 1.
4. A method for preparing a benzimidazole catalyst according to claim 3, wherein the method comprises the following steps: in the step 1), the molar ratio of the compound A to the compound B to the potassium peroxymonosulfonate is 1 (1-1.5) to 1-2, wherein the mass-volume ratio of the compound A to the DMF is 40mL/g-50 mL/g.
5. A method for preparing a benzimidazole catalyst according to claim 3, wherein the method comprises the following steps: the compounds C and R in the step (2)1NH2The molar ratio of the raw materials is 1: (1-5), the using amount of titanium tetrachloride is 1-5% of the weight ratio of the compound C, the using amount of anhydrous magnesium sulfate is 50-80% of the weight ratio of the compound C, and the mass volume ratio of the compound C to anhydrous tetrahydrofuran is 20-25 mL/g.
6. A method for preparing a benzimidazole catalyst according to claim 3, wherein the method comprises the following steps: the compounds D and [ R ] in the step (3)4NiCl(PPh3)2]Or is [ R4PdCl(PPh3)2]In a molar ratio of 1: (1-5), wherein the mass-to-volume ratio of the compound D to the anhydrous tetrahydrofuran is 15mL/g-20 mL/g.
7. Use of the benzimidazole catalyst of claim 1 in the copolymerization of norbornene with terminal linear olefins.
CN202010766030.9A 2020-08-03 2020-08-03 Benzimidazole catalyst and preparation method thereof Pending CN111825726A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202010766030.9A CN111825726A (en) 2020-08-03 2020-08-03 Benzimidazole catalyst and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202010766030.9A CN111825726A (en) 2020-08-03 2020-08-03 Benzimidazole catalyst and preparation method thereof

Publications (1)

Publication Number Publication Date
CN111825726A true CN111825726A (en) 2020-10-27

Family

ID=72920819

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202010766030.9A Pending CN111825726A (en) 2020-08-03 2020-08-03 Benzimidazole catalyst and preparation method thereof

Country Status (1)

Country Link
CN (1) CN111825726A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114643080A (en) * 2022-03-21 2022-06-21 西北大学 Olefin photodimerization catalyst and preparation method and application thereof

Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101029108A (en) * 2006-02-28 2007-09-05 中国石油化工股份有限公司 Copolymerization of ethene and norbornene
CN101081889A (en) * 2007-07-09 2007-12-05 中山大学 Preparation method of cyclolefin copolymer
CN101195643A (en) * 2007-12-03 2008-06-11 中山大学 Pyrazole imine nickel complex, produced catalyst and method for producing polynorbornene
CN101205235A (en) * 2006-12-20 2008-06-25 中国科学院化学研究所 Metal complex as well as preparation method and uses thereof
CN102690294A (en) * 2011-03-23 2012-09-26 中国石油天然气股份有限公司 2,6-diisopropyl aniline salicylaldiminato nickel, and preparation and application thereof
CN105175596A (en) * 2015-10-09 2015-12-23 天津大学 Method for catalyzing copolymerization of ethylene and norbornene
CN107602734A (en) * 2017-10-09 2018-01-19 东华大学 A kind of palladium-containing catalyst, its preparation method, by its obtained composition and application
CN109467625A (en) * 2018-09-29 2019-03-15 东华大学 Aniline oximes catalyst and preparation method thereof
CN110423306A (en) * 2019-07-03 2019-11-08 南昌大学 The double salicylaldehyde imine metal catalyst of hexa-coordinate containing heterocycle and preparation method and application
CN111116811A (en) * 2020-01-03 2020-05-08 天津大学 1-butene/norbornene copolymer and preparation method thereof

Patent Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101029108A (en) * 2006-02-28 2007-09-05 中国石油化工股份有限公司 Copolymerization of ethene and norbornene
CN101205235A (en) * 2006-12-20 2008-06-25 中国科学院化学研究所 Metal complex as well as preparation method and uses thereof
CN101081889A (en) * 2007-07-09 2007-12-05 中山大学 Preparation method of cyclolefin copolymer
CN101195643A (en) * 2007-12-03 2008-06-11 中山大学 Pyrazole imine nickel complex, produced catalyst and method for producing polynorbornene
CN102690294A (en) * 2011-03-23 2012-09-26 中国石油天然气股份有限公司 2,6-diisopropyl aniline salicylaldiminato nickel, and preparation and application thereof
CN105175596A (en) * 2015-10-09 2015-12-23 天津大学 Method for catalyzing copolymerization of ethylene and norbornene
CN107602734A (en) * 2017-10-09 2018-01-19 东华大学 A kind of palladium-containing catalyst, its preparation method, by its obtained composition and application
CN109467625A (en) * 2018-09-29 2019-03-15 东华大学 Aniline oximes catalyst and preparation method thereof
CN110423306A (en) * 2019-07-03 2019-11-08 南昌大学 The double salicylaldehyde imine metal catalyst of hexa-coordinate containing heterocycle and preparation method and application
CN111116811A (en) * 2020-01-03 2020-05-08 天津大学 1-butene/norbornene copolymer and preparation method thereof

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
WILLARD M. WELCH ET AL.: "SYNTHESIS OF 1-14C-(1S,4S)-N-METHYL-4-(3,4-DlCHLOROPHENYL)- 1,2,3,4-TETRAHYDRO-1-NAPHTHALENAMINE L-MANDEUTE", 《JOURNAL OF LABELLED COMPOUNDS AND RADIOPHARMACEUTICALS》 *
YIDING CHEN ET AL.: "Photochemical Homologation for the Preparation of Aliphatic Aldehydes in Flow", 《J. ORG. CHEM.》 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114643080A (en) * 2022-03-21 2022-06-21 西北大学 Olefin photodimerization catalyst and preparation method and application thereof
CN114643080B (en) * 2022-03-21 2023-03-10 西北大学 Olefin photodimerization catalyst and preparation method and application thereof

Similar Documents

Publication Publication Date Title
JP5712213B2 (en) Metallocene compound, catalyst composition containing the same, and olefin polymer produced using the same
CN101812145B (en) Alpha-nickel diimine compound olefin polymerization catalyst, preparation method and method for preparing branched polyethylene
CN108912009B (en) Asymmetric diimine nickel catalyst and ligand, preparation method and application thereof
CN106397261A (en) Diimine ligand compound, and complex and application thereof
CN108003259A (en) Ethenylidene acenaphthene(Alpha-diimine)Nickel alkene catalyst, preparation method and application
CN111825726A (en) Benzimidazole catalyst and preparation method thereof
CN109957049B (en) Asymmetric (alpha-diimine) nickel olefin catalyst and preparation method and application thereof
CN110423306B (en) Heterocycle-containing hexa-coordination disalicylimine metal catalyst, and preparation method and application thereof
CN109956979B (en) Heat-resistant asymmetric alpha-diimine nickel olefin catalyst and preparation method and application thereof
CN103641862B (en) A kind of method preparing crystallinity ethylene-propylene copolymer
CN112745355A (en) Complex for preparing highly branched poly (4-methyl-1-pentene) material and preparation method thereof
CN106397263A (en) Ligand compound and preparation thereof, and complex containing ligand compound
CN111233755A (en) Pyridine imine ligand, pyridine imine palladium complex based on pyridine imine ligand and catalytic application of pyridine imine palladium complex
CN105985485A (en) Method for preparing norbornylene copolymer
CN109467625B (en) Aniline oxime catalyst and preparation method thereof
JP3646334B2 (en) Method for producing cyclic olefin polymer
CN108864327A (en) 5,6- dimethyl acenaphthene(Alpha-diimine)Nickel alkene catalyst and its preparation and application
EP2526129A1 (en) Ethylene polymerisation
CN1160384C (en) Process for preparing high molecular double active center olefine polymerization catalyst
CN106397262A (en) Diimine ligand, and preparation method and application thereof
CN106349163B (en) One kind being based on the metal organic coordination polymer and the preparation method and application thereof of Cu (I)
CN112142801B (en) Asymmetric pyridine imine cobalt complex and preparation method and application thereof
CN112876513A (en) Complex for catalyzing 4-methyl-1-pentene polymerization with high activity and preparation method thereof
CN108440606B (en) Method for synthesizing titanocene dichloride
KR20120092977A (en) New transition metal compound, new organic ligand compound, catalysts composition comprising the transition metal compound and preparation method of poly-olefin using the catalysts composition

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination